Rezultaty - D. J. Richel
- Rezultaty 1 - 14 Rezultaty od 14
-
1
-
2
-
3
A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma od Christian Wülfing, Jean‐Pascal Machiels, D. J. Richel, Marc‐Oliver Grimm, Uwe Treiber, Marco R. de Groot, Philippe Beuzeboc, Roma Parikh, Frank Pétavy, Iman El‐Hariry
Wydane 2009Artigo -
4
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme od Joost J.C. Verhoeff, Olaf van Tellingen, An Claes, Lukas J.A. Stalpers, Myra E. van Linde, D. J. Richel, William P. J. Leenders, Wouter R. van Furth
Wydane 2009Revisão -
5
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006 od Liza N. van Steenbergen, M.A.G. Elferink, Pieta Krijnen, V.E.P.P. Lemmens, S. Siesling, Heidi Rütten, D. J. Richel, Henrike E. Karim‐Kos, J.W.W. Coebergh
Wydane 2010Artigo -
6
-
7
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings od Jochaim Beck, Giuseppe Procopio, Emilio Bajetta, Ulrich Keilholz, Sylvie Négrier, Cezary Szczylik, Carsten Bokemeyer, Sergio Bracarda, D. J. Richel, Michael Staehler, U.P. Strauss, Sabine Mersmann, K. Burock, Bernard Escudier
Wydane 2011Artigo -
8
Tumor microvasculature supports proliferation and expansion of glioma‐propagating cells od Tijana Borovski, Joost J.C. Verhoeff, Rosemarie ten Cate, Kate Cameron, Nienke A. de Vries, Olaf van Tellingen, D. J. Richel, Wouter R. van Furth, Jan Paul Medema, Martin R. Sprick
Wydane 2009Artigo -
9
mTOR Inhibitor Treatment of Pancreatic Cancer in a Patient With Peutz-Jeghers Syndrome od Heinz‐Josef Klümpen, Karla Queiroz, C. Arnold Spek, Carel J.M. van Noesel, Helmy C. Brink, Wendy W.J. de Leng, Roeland F. de Wilde, Elisabeth M. H. Mathus-Vliegen, G.J.A. Offerhaus, M. A. Alleman, Anneke M. Westermann, D. J. Richel
Wydane 2010Carta -
10
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients od Berta Laquente, José A. López-Martín, Donald Richards, Gerald Illerhaus, David Chang, George Kim, Philip J. Stella, D. J. Richel, Cezary Szcylik, Stefano Cascinu, Giovanni Luca Frassineti, Tudor–Eliade Ciuleanu, Karla Hurt, Scott M. Hynes, Ji Lin, Aimee Bence Lin, Daniel D. Von Hoff, Emiliano Calvo
Wydane 2017Artigo -
11
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) od Mark van Heijl, JJB van Lanschot, Linetta B. Koppert, Mark I. van Berge Henegouwen, Karin Müller, Ewout W. Steyerberg, Herman van Dekken, B.P.L. Wijnhoven, HW Tilanus, D. J. Richel, O.R. Busch, JF Bartelsman, C. C. E. Koning, G. J. A. Offerhaus, Ate van der Gaast
Wydane 2008Artigo -
12
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma od Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt, Joke W. Baars, Douwe H. Biesma, J. J. Cornellissen, Alexandra Croockewit, A. W. Dekker, W.E. Fibbe, Bob Löwenberg, Marinus van Marwijk Kooy, Marinus H. J. van Oers, D. J. Richel, Harry C. Schouten, Edo Vellenga, G. Verhoef, P. Wijermans, S. Wittebol, H M Lokhorst
Wydane 1999Artigo -
13
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer od Jolien Tol, Miriam Koopman, Annemieke Cats, C. J. Rodenburg, G.J. Creemers, J.G. Schrama, Frans Erdkamp, Allert H. Vos, Cees J. van Groeningen, Harm Sinnige, D. J. Richel, Emile E. Voest, Jeroen R. Dijkstra, M. Elisa Vink-Börger, Ninja Antonini, Linda Mol, J. Han van Krieken, Otilia Dalesio, Cornelis J.A. Punt
Wydane 2009Artigo -
14
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study od J. Schouten, Ferdinand W.N.M. Wit, Ineke G. Stolte, Neeltje A. Kootstra, Marc van der Valk, Suzanne E. Geerlings, Maria Prins, Peter Reiss, Peter Reiss, Ferdinand W.N.M. Wit, Marc van der Valk, J. Schouten, Katherine W. Kooij, Rosan A van Zoest, B C Elsenga, Maria Prins, Ineke G. Stolte, Marieke Martens, Solange Moll, Jantien van Berkel, Lars Møller, Gerben-Rienk Visser, Cris M. Welling, S Zaheri, M Hillebregt, Luuk Gras, Y M C Ruijs, D P Benschop, Peter Reiss, Neeltje A. Kootstra, A M Harskamp-Holwerda, Irma Maurer, M. M. Mangas Ruiz, A F Girigorie, Elisabeth van Leeuwen, F R Janssen, M. Heidenrijk, J. H. N. Schrijver, W Zikkenheiner, M. Wezel, C. S. M. Jansen-Kok, Suzanne E. Geerlings, Mieke H. Godfried, Abraham Goorhuis, Jan T. M. van der Meer, F.J.B. Nellen, Tom van der Poll, Jan M. Prins, Peter Reiss, Marc van der Valk, W. Joost Wiersinga, Ferdinand W.N.M. Wit, J. van Eden, A. Henderiks, A M H van Hes, M Mutschelknauss, H. Nobel, F J J Pijnappel, Anne Marie Westerman, J. de Jong, Pieter G. Postema, Peter H. Bisschop, M. J. M. Serlie, Paul Lips, E. Dekker, Sophia E. J. A. de Rooij, J M R Willemsen, Liffert Vogt, J. Schouten, Peter Portegies, Ben Schmand, Gert J. Geurtsen, Jacqueline A. ter Stege, M. Klein Twennaar, Berthe L.F. van Eck‐Smit, Menno D. de Jong, D. J. Richel, Frank D. Verbraak, Nazli Demirkaya, I. Visser, Henricus G. Ruhé, Pythia T. Nieuwkerk, Reindert P. van Steenwijk, Erica Dijkers, Charles B.L.M. Majoie, Matthan W.A. Caan, Tanja Su, H.W. van Lunsen, M A F Nievaard, Bert‐Jan H. van den Born, Erik S.G. Stroes, W. Mulder
Wydane 2014Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Chemotherapy
Oncology
Cancer
Cancer research
Biology
Environmental health
Adverse effect
Bevacizumab
Breast cancer
Colorectal cancer
Glioma
Pathology
Phases of clinical research
Population
Progression-free survival
Surgery
Capecitabine
Cell biology
Chemistry
Clinical trial
Doxorubicin
Gastroenterology
Paleontology
Pancreatic cancer
Pharmacology
Randomized controlled trial
Regimen
Trastuzumab